Home β€Ί Packaging β€Ί Packaging Technologies β€Ί Global Pharmaceutical Packaging Market

Global Pharmaceutical Packaging Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Raw Materials (Plastics and Polymers, Glass, Paper And Paperboard, Metal Foils, Others), By Pharmaceutical Dosage Type (Liquid Dosage, Solid Dosage, Semi Solid And Pressurized Products), By Packaging Type (Blister Packs, Pre-Fillable Syringes, Medical Speciality Bags, Vials And Ampoules, Pouches And Strip Bags, Others), And By Geography - Forecasts From 2025 To 2030

πŸ“₯ Download Free SampleπŸ’¬ Speak to Analyst
$3,950
Single User License
Access Full Insights
Report OverviewSegmentationTable of ContentsCustomize Report

Table of Contents

1. INTRODUCTION

1.1. Market Overview

1.2. Market Definition

1.3. Scope of the Study

1.4. Market Segmentation

1.5. Currency

1.6. Assumptions

1.7. Base, and Forecast Years Timeline

1.8. Key Benefits to the Stakeholder

2. RESEARCH METHODOLOGY  

2.1. Research Design

2.2. Research Processes

3. EXECUTIVE SUMMARY

3.1. Key Findings

3.2. CXO Perspective

4. MARKET DYNAMICS

4.1. Market Drivers

4.2. Market Restraints

4.3. Porter’s Five Forces Analysis

4.3.1. Bargaining Power of Suppliers

4.3.2. Bargaining Power of Buyers

4.3.3. Threat of New Entrants

4.3.4. Threat of Substitutes

4.3.5. Competitive Rivalry in the Industry

4.4. Industry Value Chain Analysis

4.5. Analyst View

5. GLOBAL PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL

5.1. Introduction

5.2. Plastic and Polymers

5.2.1. Market Trends and Opportunities

5.2.2. Growth Prospects

5.2.3. Geographic Lucrativeness

5.3. Glass

5.3.1. Market Trends and Opportunities

5.3.2. Growth Prospects

5.3.3. Geographic Lucrativeness

5.4. Paper and Paperboard

5.4.1. Market Trends and Opportunities

5.4.2. Growth Prospects

5.4.3. Geographic Lucrativeness

5.5. Metal Foils

5.5.1. Market Trends and Opportunities

5.5.2. Growth Prospects

5.5.3. Geographic Lucrativeness

5.6. Others

5.6.1. Market Trends and Opportunities

5.6.2. Growth Prospects

5.6.3. Geographic Lucrativeness

6. GLOBAL PHARMACEUTICAL PACKAGING MARKET, BY PHARMACEUTICAL DOSAGE TYPE

6.1. Introduction

6.2. Liquid Dosage

6.2.1. Market Trends and Opportunities

6.2.2. Growth Prospects

6.2.3. Geographic Lucrativeness

6.3. Solid Dosage

6.3.1. Market Trends and Opportunities

6.3.2. Growth Prospects

6.3.3. Geographic Lucrativeness

6.4. Semi Solid and Pressurized Products

6.4.1. Market Trends and Opportunities

6.4.2. Growth Prospects

6.4.3. Geographic Lucrativeness

7. GLOBAL PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE

7.1. Introduction

7.2. Blister Packs

7.2.1. Market Trends and Opportunities

7.2.2. Growth Prospects

7.2.3. Geographic Lucrativeness

7.3. Pre-Fillable Syringes

7.3.1. Market Trends and Opportunities

7.3.2. Growth Prospects

7.3.3. Geographic Lucrativeness

7.4. Medical Specialty Bags

7.4.1. Market Trends and Opportunities

7.4.2. Growth Prospects

7.4.3. Geographic Lucrativeness

7.5. Vials and Ampoules

7.5.1. Market Trends and Opportunities

7.5.2. Growth Prospects

7.5.3. Geographic Lucrativeness

7.6. Pouches and Strip Bags

7.6.1. Market Trends and Opportunities

7.6.2. Growth Prospects

7.6.3. Geographic Lucrativeness

7.7. Others 

7.7.1. Market Trends and Opportunities

7.7.2. Growth Prospects

7.7.3. Geographic Lucrativeness

8. GLOBAL PHARMACEUTICAL PACKAGING MARKET, BY GEOGRAPHY

8.1. Introduction

8.2. North America

8.2.1. By Raw Material

8.2.2. By Pharmaceutical Dosage Type

8.2.3. By Packaging Type

8.2.4. By Country

8.2.4.1. USA

8.2.4.1.1. Market Trends and Opportunities

8.2.4.1.2. Growth Prospects

8.2.4.2. Canada

8.2.4.2.1. Market Trends and Opportunities

8.2.4.2.2. Growth Prospects

8.2.4.3. Mexico

8.2.4.3.1. Market Trends and Opportunities

8.2.4.3.2. Growth Prospects

8.3. South America

8.3.1. By Raw Material

8.3.2. By Pharmaceutical Dosage Type

8.3.3. By Packaging Type

8.3.4. By Country

8.3.4.1. Brazil

8.3.4.1.1. Market Trends and Opportunities

8.3.4.1.2. Growth Prospects

8.3.4.2. Argentina

8.3.4.2.1. Market Trends and Opportunities

8.3.4.2.2. Growth Prospects

8.3.4.3. Others

8.3.4.3.1. Market Trends and Opportunities

8.3.4.3.2. Growth Prospects

8.4. Europe

8.4.1. By Raw Material

8.4.2. By Pharmaceutical Dosage Type

8.4.3. By Packaging Type

8.4.4. By Country

8.4.4.1. UK

8.4.4.1.1. Market Trends and Opportunities

8.4.4.1.2. Growth Prospects

8.4.4.2. Germany

8.4.4.2.1. Market Trends and Opportunities

8.4.4.2.2. Growth Prospects

8.4.4.3. France

8.4.4.3.1. Market Trends and Opportunities

8.4.4.3.2. Growth Prospects

8.4.4.4. Spain

8.4.4.4.1. Market Trends and Opportunities

8.4.4.4.2. Growth Prospects

8.4.4.5. Others

8.4.4.5.1. Market Trends and Opportunities

8.4.4.5.2. Growth Prospects

8.5. Middle East and Africa

8.5.1. By Raw Material

8.5.2. By Pharmaceutical Dosage Type

8.5.3. By Packaging Type

8.5.4. By Country

8.5.4.1. UAE

8.5.4.1.1. Market Trends and Opportunities

8.5.4.1.2. Growth Prospects

8.5.4.2. Saudi Arabia

8.5.4.2.1. Market Trends and Opportunities

8.5.4.2.2. Growth Prospects

8.5.4.3. Others

8.5.4.3.1. Market Trends and Opportunities

8.5.4.3.2. Growth Prospects

8.6. Asia Pacific

8.6.1. By Raw Material

8.6.2. By Pharmaceutical Dosage Type

8.6.3. By Packaging Type

8.6.4. By Country

8.6.4.1. Japan

8.6.4.1.1. Market Trends and Opportunities

8.6.4.1.2. Growth Prospects

8.6.4.2. China

8.6.4.2.1. Market Trends and Opportunities

8.6.4.2.2. Growth Prospects

8.6.4.3. India

8.6.4.3.1. Market Trends and Opportunities

8.6.4.3.2. Growth Prospects

8.6.4.4. South Korea

8.6.4.4.1. Market Trends and Opportunities

8.6.4.4.2. Growth Prospects

8.6.4.5. Indonesia

8.6.4.5.1. Market Trends and Opportunities

8.6.4.5.2. Growth Prospects

8.6.4.6. Others

8.6.4.6.1. Market Trends and Opportunities

8.6.4.6.2. Growth Prospects

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

9.1. Major Players and Strategy Analysis

9.2. Market Share Analysis

9.3. Mergers, Acquisitions, Agreements, and Collaborations

9.4. Competitive Dashboard

10. COMPANY PROFILES

10.1. Amcor plc

10.2. CCL Industries

10.3. Gerresheimer AG

10.4. West Pharmaceutical Services, Inc.

10.5. ONCAP (Precision Concepts International)

10.6. SVP Global (Klöckner Pentaplast)

10.7. Carl Zeiss Foundation (SCHOTT AG)

10.8. Enhanced Equity Fund (Aphena Pharma Solutions)

10.9. Sonoco Products Company

10.10. Ampersand Capital Partners (Tjoapack LLC)

REPORT DETAILS

Report ID:KSI061610047
Published:Apr 2025
Pages:138
Format:PDF, Excel, PPT, Dashboard
πŸ“₯ Download SampleπŸ“ž Speak to AnalystπŸ“§ Request Customization

Need Assistance?

Our research team is available to answer your questions.

Contact Us